BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang J, Cui PL, Lv D, Yao SW, Xu YQ, Yang ZX. Gastroesophageal reflux in cirrhotic patients without esophageal varices. World J Gastroenterol 2011; 17(13): 1753-1758 [PMID: 21483637 DOI: 10.3748/wjg.v17.i13.1753]
URL: https://www.wjgnet.com/1007-9327/full/v17/i13/1753.htm
Number Citing Articles
1
Taha M. Hassanin, Yasser Foaud, Hala Mohamed, Zienab Saad, Amr Elsayed, Sara Refaei, Wael Soliman. Prevalence and risk factors of endoscopically confirmed gastroesophageal reflux disease (GERD) in patients with liver cirrhosisEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00096-6
2
Eleni Theocharidou, Ameet Dhar, David Patch. Gastrointestinal Motility Disorders and Their Clinical Implications in CirrhosisGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/8270310
3
Mohamed Khalaf, Donald Castell, Puja Sukhwani Elias. Spectrum of esophageal motility disorders in patients with liver cirrhosisWorld Journal of Hepatology 2020; 12(12): 1158-1167 doi: 10.4254/wjh.v12.i12.1158
4
Selina Lamont, Adrian Stanley. Endoscopy in Liver Disease2017; : 155 doi: 10.1002/9781118660799.ch10
5
Hong Xu, Yang Zhou, Fangyuan Ko, Jian Ping, Jing Zhang, Changqing Zhao, Lieming Xu. Female gender and gastrointestinal symptoms, not brain‐derived neurotrophic factor, are associated with depression and anxiety in cirrhosisHepatology Research 2017; 47(3) doi: 10.1111/hepr.12723
6
Zijin Liu, Lin Wei, Huiguo Ding. Clinical characteristics of reflux esophagitis among patients with liver cirrhosis: a case-control studyScandinavian Journal of Gastroenterology 2022; 57(4): 384 doi: 10.1080/00365521.2021.2018489
7
Lívia Alves Amaral Santos, Talles Bazeia Lima, Hélio Rubens de Carvalho Nunes, Xingshun Qi, Fernando Gomes Romeiro. Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trialHepatology International 2022; 16(6): 1458 doi: 10.1007/s12072-022-10366-z
8
Tamás Janka, Tamás Tornai, Brigitta Borbély, Dávid Tornai, István Altorjay, Mária Papp, Zsuzsanna Vitális. Deleterious effect of proton pump inhibitors on the disease course of cirrhosisEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 257 doi: 10.1097/MEG.0000000000001499
9
C.-H. Chen, C.-L. Lin, C.-H. Kao. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysisOsteoporosis International 2016; 27(6): 2117 doi: 10.1007/s00198-016-3510-1
10
Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Houssam Halawi, Marco Arrese, Juan Pablo Arab. Review article: Oesophageal disorders in chronic liver diseaseAlimentary Pharmacology & Therapeutics 2024; 60(6): 715 doi: 10.1111/apt.18193
11
Toshihiro Okamoto, Haytham Elgharably, Basem Soliman, Matthew Blum, Kenneth R. McCurry. Surgical Procedures on the Cirrhotic Patient2017; : 253 doi: 10.1007/978-3-319-52396-5_20